vs
Inspire Medical Systems, Inc.（INSP）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Inspire Medical Systems, Inc.的季度营收约是Rocket Lab Corp的1.5倍（$269.1M vs $179.7M），Inspire Medical Systems, Inc.净利率更高（50.6% vs -29.5%，领先80.0%），Rocket Lab Corp同比增速更快（35.7% vs 12.2%），Inspire Medical Systems, Inc.自由现金流更多（$41.8M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 28.1%）
Inspire Medical Systems是一家专注于阻塞性睡眠呼吸暂停治疗的医疗科技企业，研发、生产并销售植入式神经刺激设备，面向无法耐受持续气道正压通气治疗的患者，核心市场覆盖北美、欧洲及部分亚太地区，服务睡眠医学、耳鼻喉科等临床领域。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
INSP vs RKLB — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $269.1M | $179.7M |
| 净利润 | $136.1M | $-52.9M |
| 毛利率 | 86.6% | 38.0% |
| 营业利润率 | 17.1% | -28.4% |
| 净利率 | 50.6% | -29.5% |
| 营收同比 | 12.2% | 35.7% |
| 净利润同比 | 286.4% | -1.1% |
| 每股收益（稀释后） | $4.57 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $269.1M | $179.7M | ||
| Q3 25 | $224.5M | $155.1M | ||
| Q2 25 | $217.1M | $144.5M | ||
| Q1 25 | $201.3M | $122.6M | ||
| Q4 24 | $239.7M | $132.4M | ||
| Q3 24 | $203.2M | $104.8M | ||
| Q2 24 | $195.9M | $106.3M | ||
| Q1 24 | $164.0M | $92.8M |
| Q4 25 | $136.1M | $-52.9M | ||
| Q3 25 | $9.9M | $-18.3M | ||
| Q2 25 | $-3.6M | $-66.4M | ||
| Q1 25 | $3.0M | $-60.6M | ||
| Q4 24 | $35.2M | $-52.3M | ||
| Q3 24 | $18.5M | $-51.9M | ||
| Q2 24 | $9.8M | $-41.6M | ||
| Q1 24 | $-10.0M | $-44.3M |
| Q4 25 | 86.6% | 38.0% | ||
| Q3 25 | 85.8% | 37.0% | ||
| Q2 25 | 84.0% | 32.1% | ||
| Q1 25 | 84.7% | 28.8% | ||
| Q4 24 | 85.0% | 27.8% | ||
| Q3 24 | 84.1% | 26.7% | ||
| Q2 24 | 84.8% | 25.6% | ||
| Q1 24 | 84.9% | 26.1% |
| Q4 25 | 17.1% | -28.4% | ||
| Q3 25 | 4.3% | -38.0% | ||
| Q2 25 | -1.5% | -41.3% | ||
| Q1 25 | -0.7% | -48.3% | ||
| Q4 24 | 13.3% | -38.9% | ||
| Q3 24 | 7.0% | -49.5% | ||
| Q2 24 | 2.6% | -40.7% | ||
| Q1 24 | -9.3% | -46.4% |
| Q4 25 | 50.6% | -29.5% | ||
| Q3 25 | 4.4% | -11.8% | ||
| Q2 25 | -1.7% | -46.0% | ||
| Q1 25 | 1.5% | -49.5% | ||
| Q4 24 | 14.7% | -39.5% | ||
| Q3 24 | 9.1% | -49.6% | ||
| Q2 24 | 5.0% | -39.2% | ||
| Q1 24 | -6.1% | -47.7% |
| Q4 25 | $4.57 | $-0.09 | ||
| Q3 25 | $0.34 | $-0.03 | ||
| Q2 25 | $-0.12 | $-0.13 | ||
| Q1 25 | $0.10 | $-0.12 | ||
| Q4 24 | $1.17 | $-0.11 | ||
| Q3 24 | $0.60 | $-0.10 | ||
| Q2 24 | $0.32 | $-0.08 | ||
| Q1 24 | $-0.34 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $308.3M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $781.2M | $1.7B |
| 总资产 | $907.3M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
| Q4 25 | $308.3M | $1.0B | ||
| Q3 25 | $322.6M | $976.7M | ||
| Q2 25 | $300.9M | $688.1M | ||
| Q1 25 | $369.2M | $428.4M | ||
| Q4 24 | $445.5M | $419.0M | ||
| Q3 24 | $411.0M | $442.4M | ||
| Q2 24 | $439.7M | $496.8M | ||
| Q1 24 | $441.4M | $492.5M |
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
| Q4 25 | $781.2M | $1.7B | ||
| Q3 25 | $666.5M | $1.3B | ||
| Q2 25 | $677.8M | $688.5M | ||
| Q1 25 | $635.7M | $431.3M | ||
| Q4 24 | $689.7M | $382.5M | ||
| Q3 24 | $696.6M | $419.8M | ||
| Q2 24 | $638.1M | $455.2M | ||
| Q1 24 | $589.0M | $478.9M |
| Q4 25 | $907.3M | $2.3B | ||
| Q3 25 | $807.7M | $2.2B | ||
| Q2 25 | $802.2M | $1.6B | ||
| Q1 25 | $730.8M | $1.3B | ||
| Q4 24 | $808.4M | $1.2B | ||
| Q3 24 | $796.2M | $1.2B | ||
| Q2 24 | $728.4M | $1.2B | ||
| Q1 24 | $685.8M | $1.2B |
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $52.5M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $41.8M | $-114.2M |
| 自由现金流率自由现金流/营收 | 15.5% | -63.6% |
| 资本支出强度资本支出/营收 | 4.0% | 27.6% |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $78.5M | $-321.8M |
8季度趋势，按日历期对齐
| Q4 25 | $52.5M | $-64.5M | ||
| Q3 25 | $68.5M | $-23.5M | ||
| Q2 25 | $2.7M | $-23.2M | ||
| Q1 25 | $-6.7M | $-54.2M | ||
| Q4 24 | $69.2M | $-2.4M | ||
| Q3 24 | $52.3M | $-30.9M | ||
| Q2 24 | $-78.0K | $-13.0M | ||
| Q1 24 | $8.9M | $-2.6M |
| Q4 25 | $41.8M | $-114.2M | ||
| Q3 25 | $58.1M | $-69.4M | ||
| Q2 25 | $-6.3M | $-55.3M | ||
| Q1 25 | $-15.1M | $-82.9M | ||
| Q4 24 | $62.2M | $-23.9M | ||
| Q3 24 | $44.3M | $-41.9M | ||
| Q2 24 | $-12.5M | $-28.3M | ||
| Q1 24 | $-2.8M | $-21.8M |
| Q4 25 | 15.5% | -63.6% | ||
| Q3 25 | 25.9% | -44.8% | ||
| Q2 25 | -2.9% | -38.3% | ||
| Q1 25 | -7.5% | -67.6% | ||
| Q4 24 | 25.9% | -18.1% | ||
| Q3 24 | 21.8% | -40.0% | ||
| Q2 24 | -6.4% | -26.7% | ||
| Q1 24 | -1.7% | -23.5% |
| Q4 25 | 4.0% | 27.6% | ||
| Q3 25 | 4.6% | 29.6% | ||
| Q2 25 | 4.1% | 22.2% | ||
| Q1 25 | 4.2% | 23.4% | ||
| Q4 24 | 2.9% | 16.3% | ||
| Q3 24 | 3.9% | 10.5% | ||
| Q2 24 | 6.3% | 14.4% | ||
| Q1 24 | 7.1% | 20.7% |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 6.90× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.24× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 2.83× | — | ||
| Q2 24 | -0.01× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INSP
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
